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A B S T R A C T
Purpose: Resective epilepsy surgery is the recommended treatment for a well-deﬁned group of patients
with drug-resistant epilepsy. Long-term outcome studies are an appropriate quality control to assess the
value of elective surgical procedures ethically and economically. This paper reports the long-term post-
surgical follow-up of adult patients of the Kork Epilepsy Centre.
Method: Data collection was performed by means of a questionnaire to obtain updated information
about postsurgical outcome, frequency and postsurgical seizure semiology in case of relapse,
postsurgical use of antiepileptic drugs, social issues and satisfaction rates. We classiﬁed seizure
outcome according to the ILAE surgery outcome scale (OC 1–OC 6).
Results: Outcome data of 340 adult patients were obtained. Mean post-operative follow-up was 6.7
years (range 1.0–21.6 years). Seizure remission was 67% if comprising patients with postoperative auras
only (OC 1 + OC 2). Sixty-two per cent of patients were completely seizure free. The majority of patients
(78%) underwent temporal lobe resections. Sixty-four per cent of these and 52% of the patients with
extra-temporal resections became completely seizure-free (OC 1). Only 34% of the patients with negative
MRI achieved complete seizure-freedom.
Conclusion: In line with others our huge cohort sample that covers decades of experience with epilepsy
surgery revealed satisfying long-term outcome results. Best results were obtained in lesional temporal
lobe epilepsy, least favourable results in MRI-negative epilepsy.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
In spite of all achievements of modern antiepileptic drug
(AED) treatment, still approximately 30–35% of patients with
epilepsy suffer from drug-resistant epilepsy.1,2 In these patients
epilepsy surgery may be the ﬁrst-line treatment option. The rate
of seizure freedom strongly depends on the epilepsy syndrome,
the brain region of interest and the presence of a MRI detectable
lesion.2 Patients with epilepsy due to hippocampal sclerosis,
focal cortical dysplasia (FCD) or dysontogenetic neuroepithelial
tumours who underwent anterior temporal lobe resection or* Corresponding author at: Epilepsiezentrum Kork, Landstrasse 1, 77694 Kehl-
Kork, Germany. Tel.: +49 7851842416; fax: +49 7851842600.
E-mail address: astaack@epilepsiezentrum.de (A.M. Staack).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.01.018lesionectomy in the temporal lobe are estimated to have a
chance of seizure remission of 60–80%.3–6 MRI-negative epilepsy
is associated with a worse outcome.4,7–13 At the Kork Epilepsy
Centre, epilepsy surgery in adults was initiated more than two
decades ago and has been consequently continued until today.
The responsible staff and the keystones of the programme
remained very stable. In terms of quality control it is necessary
to rely not only on external data and standards but also to assess
the quality of presurgical diagnostics and epilepsy surgery at our
centre compared to others and internally over the long-term. It
is even more important to evaluate the quality of our surgical
activity because of the character of an elective and irreversible
resection of brain tissue and its possible consequences such as
neuro-functional or neuro-cognitive deﬁcits. Thus, our aim was
to improve our knowledge about long-term results of epilepsy
surgery in our own series.vier Ltd. All rights reserved.
Fig. 1. Inﬂuence of the age at the time of surgery on the postsurgical outcome
Wieser 1–5 (ILAE OC 1–514) – no signiﬁcant inﬂuence was shown with one-way
analysis of variance (ANOVA).
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2.1. Patients and data collection
Our database includes all adult patients (n = 440) of the Kork
Epilepsy Centre who have undergone epilepsy surgery since 1988.
Eighty-ﬁve per cent of these patients have been operated by one of
us (JZ) and his team at the Neurosurgical Department at the
University of Freiburg, Germany.
In all of these patients clinical data were collected in detail.
Presurgical investigations took place in our tertiary epilepsy
centre. In each patient we performed long-term scalp-video-EEG-
monitoring, magnetic resonance imaging (MRI), neuropsychologi-
cal testing and – if necessary – further exams such as
ﬂuordesoxyglucose-positron-emission-tomography (FDG-PET),
high-ﬁeld MRI (1.5–3.0 T), voxel-based morphometry, functional
MRI (language and motor), Wada-test, ictal and interictal single
photon emission computed tomography (SPECT) or magnetoen-
cephalography (MEG). Patients were investigated with invasive
recordings (subdural and depth electrodes), when non-invasive
presurgical evaluation did not allow proper deﬁnition of the limits
of resection or to identify eloquent cortex. Invasive recordings
were performed at the University of Freiburg.
A special case conference designated to surgical candidates was
held to discuss the results of the presurgical evaluation and to
decide the extent and limits of resection in each particular case.
Postoperative controls included clinical examination, evalua-
tion of seizure remission or relapse, interictal EEG, MRI and
neuropsychological testing in each patient and were routinely
performed three months and one year after surgery. If a patient
was not seizure-free, long-term video-EEG with ictal recordings
was performed again.
Our database contained information about the kind of surgery,
histopathology and postsurgical complications.
2.1.1. Assessment of update post-operative outcome data
We used a standardized questionnaire to obtain updated
information about postsurgical outcome as seizure-remission,
frequency and kind of seizures when relapse in comparison to the
pre-operative seizure frequency, information about AED treatment
as well as patient’s satisfaction and actual social and professional
situation. This questionnaire permitted us to reach 320 of the total
440 operated patients who live far away from our centre. Two
hundred and twenty patients ﬁlled in the questionnaire and sent it
back in between 3 months. If the questionnaire was not ﬁlled out
correctly, we called patients and their relatives to clarify our
questions. In addition, those 120 patients who had been identiﬁed
by means of the database mentioned above and lived close to our
centre were seen together with family members or friends
between March and May 2011 in our outpatient’s department.
Each patient gave us individual consent to use the data for study
purpose.
2.2. Seizure outcome classiﬁcation
We classiﬁed seizure outcome at the time of the post-surgery
follow-up evaluation (most recent observation, means March–May
2011) according to the ILAE (International League Against
Epilepsy) surgery outcome scale (OC 1–OC 6).14,15 According to
this, patients had at least been seizure-free (OC 1) in the previous
year before the time of the last recent observation.
ILAE outcome scale (OC)14
 OC 1: completely seizure free, no auras
 OC 2: only auras, no other seizures
 OC 3: one to three seizure days per year  auras OC 4: four seizure days per year to 50% reduction of baseline
seizure days  auras
 OC 5: less than 50% reduction of baseline seizure days to 100%
increase of baseline seizure days  auras
 OC 6: more than 100% increase of baseline seizure days  auras.
2.3. Statistical analysis
The total number and percentage were achieved for the non-
parametric variables.
For qualitative variables, the statistical differences were
calculated using the chi-square test. For continuous values, one-
way analysis of variance (ANOVA) was run with Statistica
(Statsoft1, version 8.0).
3. Results
3.1. Demographic data
Out of a total of 440 patients we were able to obtain complete
outcome data of 340 patients at the last observation carried
forward. One-hundred patients could not be included due to a loss
of current addresses, a lack of motivation to participate, interfering
confounding factors such as psychogenic seizures or death (n = 5).
Mean follow-up since surgery was 6.7 years (range 1–21.6
years).
174 male and 166 female patients participated in this study.
Mean duration of epilepsy until surgery was 24.9 years (range 1–
56 years); mean age at the time of surgery was 38.6 years (range
18–69). Neither the age at the time of surgery nor the duration of
epilepsy had any inﬂuence on the post-operative outcome in our
series as illustrated in Figs. 1 and 2, even if we addressed subgroups
(duration of epilepsy before epilepsy surgery: 1–10 years;
>10 < 20 years; >20 years).
3.2. Post-operative outcome in the whole population
At the time of the last recent observation in May of 2011, 211
patients (62%) were completely seizure-free (OC 1) for at least one
year. Including patients who have had seizure remission except
auras (OC 1 + OC 2) the number increased to 228 (67%). If surgery
had taken place less than 7 years ago (n = 194), the percentage of
Fig. 2. Inﬂuence of the duration of epilepsy on the postsurgical outcome Wieser 1–5
(ILAE OC 1–514) – no signiﬁcant inﬂuence was shown with one-way analysis of
variance (ANOVA).
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group of patients who had undergone surgery more than 7 years
ago (7–21 years postoperatively) (n = 146) the rate of seizure-
freedom was 65% (OC 1) and 72% (OC 1 + OC 2).
Fig. 3 shows the number and percentage of patients in the
different postsurgical outcome categories (ILAE outcome classiﬁ-
cation).14
In 39 patients (11.5%) seizures (including auras) still had been
documented during the ﬁrst year after surgery but had not been
reported anymore at the time of the last recent observation.
Thirty-three (85%) of these patients had undergone temporal
lobe resections, 5 frontal lobe resections and one patient had a
multilobar resection.
AED treatment was changed post-operatively in 17 of these 39
patients. Thirteen patients received levetiracetam additionally to
their pre-operative AEDs or in exchange with one of the pre-
operative AEDs. In four further patients other AEDs than
levetiracetam were contributed. In six of the 39 patients, pre-
operative AEDs were reduced or even discontinued regardless of
initially continuing seizures. Sixteen patients remained on their
pre-operative AEDs.
Otherwise, 25 patients (7%) did not have any seizures in the ﬁrst
year after surgery but seizure relapse (OC 3; 4; 5) was noted at the
time of the last recent observation.Fig. 3. Outcome after epilepsy surgery at last recent observation in May 2011; in
total 340 patients. Number of patients in the different categories OC 1–OC 5 (ILAE-
outcome classiﬁcation14). None of the patients was classiﬁed OC 6.3.3. Post-operative outcome in elderly patients
Twelve patients were 60 years or older (range from 60 to 69
years) at the time of surgery. Six patients were resected in the left
temporal lobe, ﬁve in the right temporal lobe and one patient had a
right frontal resection. Four patients got completely seizure-free,
one patient reported occasional auras only. Three patients had a
signiﬁcant seizure reduction. Four patients did not beneﬁt.
3.4. Post-operative outcome in relation to the resected brain region
3.4.1. Temporal lobe resections
Two-hundred and sixty-six (78%) patients underwent temporal
lobe resections. The seizure-free rate (OC 1) in this group was 64%
(n = 171). Taking completely seizure-free patients and patients
with only persisting auras in account (OC 1 + OC 2), seizure
remission was reported in 69.5% (n = 185). Forty-three (16.2%)
patients were classiﬁed as OC 3, 27 (10.2%) as OC 4 and 11 as OC 5
(4%).
Table 2 shows the number and percentage of seizure-free
patients after selective amygdalo-hippocampectomy (sAHE) and
standard anterior temporal lobe resection (ATL) + amygdalo-
hippocampectomy.
A small group of eight patients with subtle blurring of the
temporal pole without MRI-signs of hippocampal sclerosis
underwent anterior temporal lobe resection without removal of
the hippocampus. Six patients have remained seizure-free (OC 1).
Thirty-four patients with clear MRI lesions as, for example,
dysontogenetic neuroepithelial tumours or Taylor type dysplasia
underwent temporal lesionectomies with a seizure-free rate of 62%
(OC 1).
3.4.2. Extra-temporal lobe resections
Forty-eight patients had extra-temporal resections among
which 37 patients were resected in the frontal, 2 in the basal
central region, 5 in the parietal lobe, 2 in the occipital region and
another 2 in the insula. Fifty-two per cent (n = 25) of patients with
extra-temporal resections were seizure-free (OC 1; 56%: OC 1 + OC
2). Twelve patients were considered as MRI-negative.
Only four of these remained seizure free (OC 1).
3.4.3. Multilobar resections and hemispherotomies
If multilobar resections (n = 21) were performed, 52.4% of the
patients became seizure-free (OC 1; 57%: OC 1 + OC 2).
3.4.4. Hemispherotomies
Five adult patients with hemispherotomies were completely
seizure-free (OC 1). This series has already been described
elsewhere.16
3.5. Postsurgical outcome in relation to the histopathological result
In resections that comprised temporal lobe tissue, the
histopathological examination revealed 208 cases of hippocampal
sclerosis, 88 focal cortical dysplasias (including combinations with
tumours and/or hippocampal sclerosis) and 28 tumours (dyson-
togenetic neuroepithelial tumours, ganglioglioma, gangliocytoma;
low-grade oligodendroglioma and astrocytoma, hamartoma,
ependymoma) as well as 11 vascular malformations (cavernoma,
haemangioma, meningoangiomatosis). In 68 cases hippocampal
sclerosis and FCD were combined. Following Palmini’s classiﬁca-
tion17 the histopathological result showed 9 FCD type Ia, 21 FCD
type Ib, 29 FCD type IIa and one FCD type IIb as well as 8 not
speciﬁcally classiﬁed FCDs in combination with hippocampal
sclerosis. The rate of seizure freedom (OC 1) was 68% (72%: OC
1 + OC 2) in these patients with dual pathology. In the subgroup of
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1) reached 67% (70%: OC 1 + OC 2). For extra-temporal lobe
resections, histopathology showed in total 29 FCD, 18 FCD type II
and 11 FCD type I as well as 9 tumours, 3 cavernomas, and 7 cases
of gliosis.
Interestingly, the rate of seizure freedom in type I and type II
dysplasias was the same in these small groups (9 patients OC 1 in
FCD type II group; n = 18 and 5 patients in FCD type I group; n = 11).
3.6. MRI-negative patients
Only 26 (7.6%) patients were classiﬁed as MRI-negative. All
MRIs were performed according to the epilepsy protocol with 1.5-T
or 3.0-T (since 2005) systems including thin coronal T2- and ﬂuid-
attenuated inversion recovery (FLAIR)-weighted sections as well as
thin T2, T1 and FLAIR-weighted axial and sagittal images, MPRAGE
(magnetization-prepared rapid gradient echo) sequences and 3-
dimensional T1 data sets. Axial images were acquired with a
modiﬁed angulation parallel to the long axis of the temporal lobe.
Since 2004 we have used post-processing (voxel-based morpho-
metric MRI-analysis) for the detection of subtle signs of FCD.18 In
all these patients invasive video-EEG recording had been
performed mainly with subdural electrodes or combinations of
subdural and depth electrodes prior to surgery.
Only 34.6% of MRI-negative patients had complete (OC 1) and
38.5% almost complete seizure-remission (OC 1 + OC 2). Twelve
patients had extra-temporal resections, nine temporal and ﬁve
multilobectomies. Histopathology showed FCD types Ia and Ib in
18, FCD + hippocampal sclerosis in six and undeﬁned tissue
abnormalities in two cases.
3.7. Palliative surgery
Fourteen patients were operated based on a ‘‘palliative’’
perspective. We considered surgery to be palliative if it was
performed primarily to reduce seizures or to suppress very disabling
seizures (tonic seizures with falls, tonic–clonic seizures, etc.). We
were aware that complete seizure freedom would be difﬁcult to
achieve because of multi-focal seizure onset, large seizure onset
zones or extent of the seizure onset zone to eloquent cortex. There
were ﬁve resections in the temporal lobe (3 sAHE, one lesionectomy
and one AHE + ATL). The rest were frontal, central and occipital
lesion- and lobectomies as well as two multilobectomies. In eight
patients multiple subpial transsections were additionally performed
and in eight patients invasive video-EEG recordings preceded the
resection. Four patients became seizure-free.
One patient was classiﬁed as OC 2, another one as OC 3, ﬁve
patients as OC 4 and three as OC 5.
3.8. Postsurgical outcome in patients with invasive recordings
Seventy-three (21.5%) of the 340 patients had obtained invasive
video-EEG recordings with subdural and/or depth electrodes prior
to resection. Thirty-ﬁve (48%) patients were classiﬁed as OC 1 at
the time of last recent observation, 42 (57.5%) as OC 1 + OC 2.
Thirty-six patients underwent temporal resections after invasive
recordings. Twenty-one frontal/fronto-central resections were
performed. The remaining 16 extra-temporal resections were
parietal, insular and partially or completely multilobar procedures.
OC 1 + OC 2 was achieved in 64% of temporal and in 51% of extra-
temporal resections.
3.9. Surgical complications
Twenty of the 340 patients (5.9%) had peri-operative complica-
tions (haemorrhage, infection). Most of these patients had onlytransient deﬁcits and 50% became seizure-free (ILAE outcome
classiﬁcation: OC 1). The complication rate for permanent deﬁcits
(hemiparesis, aphasia and neurocognitive deﬁcits) was 1.8%.
Six of 73 patients (8.1%) who had undergone invasive video-EEG
recordings with subdural electrodes had complications (ﬁve
subdural bleedings, one subdural bleeding and abscess) with
transient deﬁcits.
No deaths occurred.
3.10. Post-operative AED treatment
Forty-one patients (12%) had discontinued AEDs at the last time
of observation and have remained seizure-free. In ten further
patients seizure relapse occurred after drug-withdrawal. One-
hundred and thirty-seven patients continued one AED, 134 two
and 29 even three or more AEDs.
3.11. Post-operative satisfaction
295 (87%) patients declared to be satisﬁed about surgery and
postsurgical outcome. 191 (66%) of these 295 satisﬁed patients had
seizure remission.
4. Discussion
We evaluated the post-operative seizure outcome of our adult
patients over the past twenty years. Although others have reported
their series already, for reasons of internal and external (health
insurances, caregivers) quality control it is crucial to assess the
long-term outcome of epilepsy surgery at our centre which
represents one of the largest tertiary referral centres in Germany.
From a methodological point of view the main advantages of our
series are clearly the homogeneous and stable staff and standard-
ized diagnostic and therapeutic procedures over decades.
4.1. Epilepsy outcome
At the time of the last postsurgical follow-up, 211 patients
(62%) were completely seizure-free corresponding to ILAE
outcome classiﬁcation 1 (OC 1).
This number increased to 228 (67%) if patients were included
who had seizure-remission apart from auras (OC 1 + OC 2).
4.2. Seizure remission and relapse
Thirty-nine patients (11.5%), mainly with temporal resections
had seizures in the ﬁrst post-operative year, but were seizure-free
at the last observation evoking a running down phenomenon, as
described by Salanova, Rasmussen et al.19 In 17 of these 39
patients, pre-operative AEDs were changed post-operatively.
Levetiracetam was administrated postoperatively in 13 patients
who ﬁnally became seizure-free in course of the years which might
have had a positive impact on the long-term outcome as described
in a recently published study.20 Otherwise 16 patients remained on
their pre-operative AED treatment and in six patients AEDs had
even been reduced or discontinued before they became completely
seizure-free. Thus the running down phenomenon cannot only be
explained by changes in AED treatment. Other factors such as the
size of the epileptogenic zone may also contribute.19
Twenty-ﬁve patients (7%) of the whole collective had seizure
relapses at the last follow-up despite of stable AED treatment.
Late recurrence after an initial seizure-free period of more than
two years has often been reported. In a recently published cohort
study of 615 adults, the seizure-remission rate was estimated
using survival methods at 63% at two years after surgery, 52% at
ﬁve years and 47% at ten years (OC 1 + OC 2; persisting auras
Table 2
Postsurgical outcome of selective amygdalo-hippocampectomy (sAHE) and
classical anterior temporal lobe resection (AHE + ATL). OC 1 versus patients with
persistent seizures: there is no signiﬁcant effect based on the surgery method chi-
square, p = 0.36. OC 1 + OC 2 versus patients with persistent seizures: there is no
signiﬁcant effect based on the surgery methods chi-square, p = 0.17.
Outcome classiﬁcation sAHE
n = 124
AHE + ATL
n = 100
1 n = 78 (63%) n = 66 (66%)
2 n = 9 (7%) n = 3 (3%)
3 n = 18 (15%) n = 19 (19%)
4 n = 14 (11%) n = 8 (8%)
5 n = 5 (4%) n = 4 (4%)
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annual relapse rate of 4% between 5 and 10 years after epilepsy
surgery.
Our study does not provide a longitudinal year-by-year follow-
up. Therefore we are not able to give the percentage of patients
with seizure relapse depending on the time after surgery.
Regarding data and study design, we are able to report on a
subgroup who had undergone epilepsy surgery more than 7 years
ago. Positive outcome rates were higher with 65–72% (OC 1/OC
1 + OC 2) compared with 62% in the more recently operated
patients. This result may be due to a selection bias. At the
beginnings of our epilepsy surgery programme we chose only the
best candidates with clearly well-deﬁned brain lesions and
perfectly corresponding semiological and surface-EEG features.
We lack to see those patients regularly recently. Hopefully good
epilepsy surgery candidates with epilepsy onset in childhood or
adolescence are identiﬁed earlier today and led to surgery.
Furthermore the incidence of hippocampal sclerosis may be less
important in well-developed countries nowadays thanks to the
considerable progress in obstetrics.
4.3. Age at the time of surgery and duration of epilepsy
Conversely to previous outcome studies22–24 neither the age at
the time of surgery nor the duration of epilepsy were signiﬁcantly
inﬂuencing the post-operative outcome in our series, even not in a
subgroup analysis. However the three different subgroups (see
Table 1) enclosed a very unequal number of patients with only 52
patients in subgroup 1, 86 in subgroup 2 but 202 patients in
subgroup 3 which renders the three different groups hardly
comparable. McIntosh et al.25 showed that age at surgery and
duration of epilepsy had signiﬁcant effect on univariate analysis
but not on regression analysis after pre-operative pathology and
pre-operative generalized seizures had been taken into account.
Maybe these or other confounding factors were inﬂuencing our
results.
Mean duration of epilepsy was long with 24.9 years and mean
age at the time of surgery was 38.6 years.
Engel et al.26 recently compared a medically treated group of
patients with pharmaco-resistant epilepsy and a surgically treated
one. They concluded that surgical plus AED treatment resulted in a
lower probability of seizures, than AED treatment alone. Keeping in
mind the results of this study, patients should be referred to
surgery early after failure of two correctly administrated and well-
established AEDs, which was apparently not the rule in our series.
4.4. Epilepsy outcome in the elderly
Even if the mean age at the time of surgery did not differ
signiﬁcantly, regarding the postsurgical outcome in the entireTable 1
Number of seizure-free patients in the different subgroups considering the duration
of epilepsy-no signiﬁcant differences in seizure outcome between the subgroups;
subgroups 1 and 2, p = 0.95; subgroups 1 and 3, p = 0.93; subgroups 2 and 3, p = 0.88.
Subgroups: duration
of epilepsy before
surgery
Number of completely
seizure-free patients
(OC 1)
Number of seizure-free
patients apart from
auras (OC 1 + OC 2)
Subgroup 1
1–10 years
n = 52
31 (60%) 34 (65%)
Subgroup 2
>10 < 20 years
n = 86
51 (60%) 57 (66%)
Subgroup 3
>20 years
n = 202
129 (64%) 137 (68%)cohort, a qualitative analysis showed that patients with an age of
60 years or higher had a less favourable outcome. The group was
small with only twelve patients. Four patients became completely
seizure free at the time of last follow-up, one patient experienced
only non-disabling auras. Most post-operative outcome studies of
elderly patients did not show worse results compared to the
outcome in younger age groups.27–29 However, the older age group
was deﬁned as age >50 years which reﬂects an ‘‘old age group’’
quite young compared to our contemporary understanding of
seniority. One recent study showed clearly a more favourable
outcome in the younger age group <50 years.30
4.5. Signiﬁcance of the brain region and presence of a lesion
In our series post-operative outcome was strongly depending
on the presence of a MRI-visible lesion and its localization in the
brain.
Post-operative seizure freedom in MRI-negative patients was
only 34.6% (OC 1), which is in line with the literature.31 Bien et al.32
reported in a retrospective study of patients with MRI-negative
epilepsy, only 38% seizure-free cases, whereas 66% of MRI-positive
patients had seizure remission.
4.6. Temporal versus extra-temporal resections
The majority of patients (n = 266) underwent temporal lobe
surgery. In this subgroup the seizure-remission rate was 69.5%
including totally seizure-free patients and patients with only non-
disabling auras at the last time of observation (mean post-
operative follow-up 7.14 years). In the literature long-term
outcome-rates after temporal lobe resection differ from 55 to
77% at two years follow-up, from 48 to 74% at ﬁve years follow-up
and 41 to 72% at 10 years follow-up.25,33–37
In our series, 56% of patients who underwent extra-temporal
resections achieved long-term seizure –freedom. In a recently
published study the probabilities of seizure-freedom at one year
follow-up were only 23.5% and at ﬁve years follow-up 14.7% after
extra-temporal epilepsy surgery.38 In a meta-analysis of 131
patients it was shown that outcome in extra-temporal lobe
epilepsy is less favourable than in temporal lobe epilepsy.39
Zentner et al.40 reported on 54% of patients with extra-temporal
resections who remained seizure-free over a four year follow-up
period. Better outcome was achieved when a lesion had been
detected before surgery.40–42
4.7. Continuation or withdrawal of AEDs
The number of patients with complete drug withdrawal after
surgery was small (12%). If inacceptable side effects were not
apparent, we did not begin with AED tapering in the ﬁrst post-
operative year. A recently published study showed that beginning
of AED taper more than nine months after surgery was associated
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wished to stay on AEDs, mostly for professional or social reasons
such as the driver’s licence. Ten patients had seizure relapse after
AED withdrawal but regained seizure freedom after restarting AED
treatment in line with one other report.44 Seizure recurrence after
AED withdrawal was described in one out of three patients
rendered seizure free by epilepsy surgery.45 We did not
recommend AED-withdrawal in patients who presented with
post-operative auras and/or interictal epileptiform discharges,
incomplete resection, FCD type I or pre-operative negative MRI,
respectively, since those factors are associated with an increased
risk of seizure recurrence.39,46–50
4.8. Post-operative tonic–clonic seizures
Thirty-three per cent of patients who did not achieve seizure
freedom (ILAE outcome classiﬁcation OC 3–OC 5; n = 112)
experienced mainly sleep-related tonic–clonic seizures which
had not been their dominating semiology pre-operatively. Most of
them had temporal lobe resections including neocortical tissue.
Post-operative interictal EEG showed the irritative zone at
electrodes placed over the resected region. Ictal EEG in those
who were re-evaluated with scalp video-EEG registration revealed
a remaining ictal onset zone around the resected brain area. This
preponderance of tonic–clonic seizures may be due to a fast
propagation pathway from remaining epileptogenic tissue in the
vicinity of the temporal resection borders to suprasylvian areas.
In conclusion, our study shows satisfying postsurgical long-
term outcome results in patients who had underwent surgery for
medically intractable epilepsy. Best candidates remain patients
with temporal lobe epilepsy in whom a MRI visible lesion is
present. Information about postsurgical seizure outcome is crucial
to reﬂect critically on the quality of our work, select patients
carefully for a successful outcome and to be able to give a realistic
prognosis to the individual patient. Data assessment for quality
properties in health care may play an evermore important role to
justify clinical activity such as elective surgical procedures in
epilepsy.
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